Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9793 - 9800 of 12015 results
2015 Health Care Reform Compliance Checklist for Employers
January 23, 2015| Blog| Viewpoint
DC’s New Wage Theft Law Imposes Additional Notice, Posting, and Recordkeeping Requirements on Employers
January 23, 2015| Blog| Viewpoint
California Sunshine Warms the Market: A Twist on Customer Non-Solicitation Provisions in the Golden State
January 23, 2015| Blog| Viewpoint
Massachusetts Senate Creates Special Committee on Marijuana
January 23, 2015| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on January 20, 2015
January 23, 2015| Blog| Viewpoint
Energy Debates Off to a Hot Start in 2015: ML Strategies Energy and Environment Update
January 22, 2015| Blog| Viewpoint
Massachusetts Senate Committee Leadership Established, Signaling Priorities
January 22, 2015| Alert| Viewpoint
Albany County, NY Enacts Stringent Children’s Product Safety Law
January 21, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|